Incyte (INCY) Common Equity (2009 - 2026)
Incyte (INCY) posted Common Equity of $5.64 billion for Q3 2026, up 21.3% from $4.65 billion a year earlier but down 11.1% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Incyte's Common Equity came in at $5.17 billion, up 49.9% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- In prior years, Incyte's Common Equity was $3.45 billion in FY2024 (-33.6%), $5.19 billion in FY2023 (+18.8%), $4.37 billion in FY2022 (+15.9%) and $3.77 billion in FY2021 (+44.4%).
- Quarterly Common Equity has run from a low of $3 billion in Q2 2024 to a high of $6.34 billion in Q2 2026 over five years.
- On a year-over-year basis, Common Equity has increased in each of the last six quarters, with growth averaging 24.6% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2026, with growth of 53.3%; the weakest was Q2 2024, with a decline of 36.8%.
- According to Business Quant data, Common Equity for the three prior quarters was $6.34 billion (Q2 2026), $5.62 billion (Q1 2026) and $5.17 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 5.64 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.64 Bn |
| Jun 30, 2026 | 6.34 Bn |
| Mar 31, 2026 | 5.62 Bn |
| Dec 31, 2025 | 5.17 Bn |
| Sep 30, 2025 | 4.65 Bn |
| Jun 30, 2025 | 4.17 Bn |
| Mar 31, 2025 | 3.67 Bn |
| Dec 31, 2024 | 3.45 Bn |
| Sep 30, 2024 | 3.17 Bn |
| Jun 30, 2024 | 3.00 Bn |
| Mar 31, 2024 | 5.39 Bn |
| Dec 31, 2023 | 5.19 Bn |
| Sep 30, 2023 | 4.93 Bn |
| Jun 30, 2023 | 4.74 Bn |
| Mar 31, 2023 | 4.46 Bn |
| Dec 31, 2022 | 4.37 Bn |
| Sep 30, 2022 | 4.23 Bn |
| Jun 30, 2022 | 4.09 Bn |
| Mar 31, 2022 | 3.86 Bn |
| Dec 31, 2021 | 3.77 Bn |
API Access
Incyte Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();